4-thioxo-4,7-dihydro-thieno[2,3-b]pyridine-5-carboxamides as antiviral agents
US6620810B2 · kind B2 · utility
4Cited by
6References
30Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Aug 29, 2002 |
| Grant date | Sep 16, 2003 |
| Priority date | — |
| Expiry date | Aug 29, 2022 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides a compound of formula I: wherein R1, R2, R3, and R4 have any of the values defined in the specification, or a pharmaceutically acceptable salt thereof, as well as processes and intermediates useful for preparing such compounds or salts, and methods of treating a herpesvirus infection, atherosclerosis or restenosis using such compounds or salts.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.